Blood sampling technology developer Essenlix was co-founded by Stephen Chou, a professor of electrical engineering at Princeton University.
Essenlix, a US-based blood sampling technology company that emerged out of Princeton University, has disclosed a total of $20m from backers including Quadrant Management, Carret Private Investments and unnamed angel investors, Business Insider has reported.
The report did clarify whether the $20m came from multiple rounds or when the capital was provided. We have reached out to Essenlix and will update as appropriate.
Essenlix has designed a blood sampling system called iMost that attaches to an iPhone to provide full-body…
